180 Diabetes Drugs in Development

America’s biopharmaceutical research companies currently are developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide. These medicines in development — all either in clinical trials or under review by the FDA — include 30 for type 1 diabetes, 100 for type 2 and 52 for diabetes-related conditions. Pharmaceutical Research and Manufacturers of America